In the case of KIT-mutant melanomas, it is important to define the KIT-inhibitor sensitive ones based on experiences with KIT inhibitor efficacy in gastrointestinal stromal tumor (GIST). The gene discussed is KIT; the disease is gastrointestinal stromal tumor.